Table of Contents

1. Introduction
 1.1 Market Definition & Scope
 1.2 Research Assumptions & Abbreviations
 1.3 Research Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2035
 2.3 Market Size & Forecast, By Segmentation, 2022 – 2035
  2.3.1 Market Size By Product Life Cycle
  2.3.2 Market Size By Service Provider
  2.3.3 Market Size By Type
  2.3.4 Market Size By Process Flow
  2.3.5 Market Size By Therapeutic Area
  2.3.6 Market Size By End Use
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO's Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter's) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1 Software & Solution Providers
  3.4.2 Contract Research Organizations
  3.4.3 Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers (End-Users)
  3.4.4 Regulatory Authorities (Stakeholders)
 3.5 Industry Life Cycle Assessment
 3.6 Parent Market Overview (Drug Safety & Regulatory Affairs)
 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting
 4.1 Adverse Event Reporting Metrics
  4.1.1 Overview
  4.1.2 Global Adverse Event Report Volume & Growth Trends
  4.1.3 Average Case Processing Time by Region & Severity
  4.1.4 Regulatory Submission Timelines & Compliance Rates
  4.1.5 Serious Adverse Event vs. Non-Serious Event Distribution

 4.2 Technology Adoption & Automation Metrics
  4.2.1 Overview
  4.2.2 AI & Machine Learning Integration Rate in Safety Monitoring
  4.2.3 Cloud-Based Platform Adoption vs. On-Premise Solutions
  4.2.4 Natural Language Processing Utilization in Case Intake
  4.2.5 Automated Signal Detection System Implementation Rates

 4.3 Regulatory Compliance & Quality Metrics
  4.3.1 Overview
  4.3.2 ICH E2B Compliance Rates by Geographic Region
  4.3.3 Periodic Safety Update Report Submission Accuracy
  4.3.4 Regulatory Inspection Findings & Warning Letter Trends
  4.3.5 Risk Management Plan Implementation Effectiveness

 4.4 Outsourcing & Resource Utilization Metrics
  4.4.1 Overview
  4.4.2 Contract Research Organization Service Utilization Rates
  4.4.3 Average Cost Savings Through Pharmacovigilance Outsourcing
  4.4.4 Pharmacovigilance Professional Certification & Training Trends
  4.4.5 In-House vs. Outsourced Case Volume Distribution

5. Pharmacovigilance Market Segmental Analysis & Forecast, By Product Life Cycle, 2022 – 2035, Value (USD Million)
 5.1 Introduction
 5.2 Pre-clinical
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Phase I
 5.4 Phase II
 5.5 Phase III
 5.6 Phase IV

6. Pharmacovigilance Market Segmental Analysis & Forecast, By Service Provider, 2022 – 2035, Value (USD Million)
 6.1 Introduction
 6.2 In-house
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022 – 2035
 6.3 Contract Outsourcing

7. Pharmacovigilance Market Segmental Analysis & Forecast, By Type, 2022 – 2035, Value (USD Million)
 7.1 Introduction
 7.2 Spontaneous Reporting
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022 – 2035
 7.3 Intensified ADR Reporting
 7.4 Targeted Spontaneous Reporting
 7.5 Cohort Event Monitoring
 7.6 EHR Mining

8. Pharmacovigilance Market Segmental Analysis & Forecast, By Process Flow, 2022 – 2035, Value (USD Million)
 8.1 Introduction
 8.2 Case Data Management
  8.2.1 Case Logging
  8.2.2 Case Data Analysis
  8.2.3 Medical Reviewing & Reporting
 8.3 Signal Detection
  8.3.1 Adverse Event Logging
  8.3.2 Adverse Event Analysis
  8.3.3 Adverse Event Review & Reporting
 8.4 Risk Management System
  8.4.1 Risk Evaluation System
  8.4.2 Risk Mitigation System

9. Pharmacovigilance Market Segmental Analysis & Forecast, By Therapeutic Area, 2022 – 2035, Value (USD Million)
 9.1 Introduction
 9.2 Oncology
  9.2.1 Key Trends
  9.2.2 Market Size & Forecast, 2022 – 2035
 9.3 Neurology
 9.4 Cardiology
 9.5 Respiratory Systems
 9.6 Others

10. Pharmacovigilance Market Segmental Analysis & Forecast, By End Use, 2022 – 2035, Value (USD Million)
 10.1 Introduction
 10.2 Pharmaceuticals
  10.2.1 Key Trends
  10.2.2 Market Size & Forecast, 2022 – 2035
 10.3 Biotechnology Companies
 10.4 Medical Device Manufacturers
 10.5 Others

11. Pharmacovigilance Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Million)
 11.1 Introduction
 11.2 North America
  11.2.1 Key Trends
  11.2.2 Pharmacovigilance Market Size & Forecast, By Product Life Cycle, 2022 – 2035
  11.2.3 Pharmacovigilance Market Size & Forecast, By Service Provider, 2022 – 2035
  11.2.4 Pharmacovigilance Market Size & Forecast, By Type, 2022 – 2035
  11.2.5 Pharmacovigilance Market Size & Forecast, By Process Flow, 2022 – 2035
  11.2.6 Pharmacovigilance Market Size & Forecast, By Therapeutic Area, 2022 – 2035
  11.2.7 Pharmacovigilance Market Size & Forecast, By End Use, 2022 – 2035
  11.2.8 Pharmacovigilance Market Size & Forecast, By Country, 2022 – 2035
   11.2.8.1 USA
   11.2.8.2 Canada

 11.3 Europe
  11.3.1 Key Trends
  11.3.2 Pharmacovigilance Market Size & Forecast, By Product Life Cycle, 2022 – 2035
  11.3.3 Pharmacovigilance Market Size & Forecast, By Service Provider, 2022 – 2035
  11.3.4 Pharmacovigilance Market Size & Forecast, By Type, 2022 – 2035
  11.3.5 Pharmacovigilance Market Size & Forecast, By Process Flow, 2022 – 2035
  11.3.6 Pharmacovigilance Market Size & Forecast, By Therapeutic Area, 2022 – 2035
  11.3.7 Pharmacovigilance Market Size & Forecast, By End Use, 2022 – 2035
  11.3.8 Pharmacovigilance Market Size & Forecast, By Country, 2022 – 2035
   11.3.8.1 Germany
   11.3.8.2 UK
   11.3.8.3 France
   11.3.8.4 Italy
   11.3.8.5 Spain
   11.3.8.6 Russia
   11.3.8.7 Poland
   11.3.8.8 Rest of Europe

 11.4 Asia-Pacific
  11.4.1 Key Trends
  11.4.2 Pharmacovigilance Market Size & Forecast, By Product Life Cycle, 2022 – 2035
  11.4.3 Pharmacovigilance Market Size & Forecast, By Service Provider, 2022 – 2035
  11.4.4 Pharmacovigilance Market Size & Forecast, By Type, 2022 – 2035
  11.4.5 Pharmacovigilance Market Size & Forecast, By Process Flow, 2022 – 2035
  11.4.6 Pharmacovigilance Market Size & Forecast, By Therapeutic Area, 2022 – 2035
  11.4.7 Pharmacovigilance Market Size & Forecast, By End Use, 2022 – 2035
  11.4.8 Pharmacovigilance Market Size & Forecast, By Country, 2022 – 2035
   11.4.8.1 China
   11.4.8.2 India
   11.4.8.3 Japan
   11.4.8.4 South Korea
   11.4.8.5 Australia
   11.4.8.6 ASEAN Countries
   11.4.8.7 Rest of Asia-Pacific

 11.5 Latin America
  11.5.1 Key Trends
  11.5.2 Pharmacovigilance Market Size & Forecast, By Product Life Cycle, 2022 – 2035
  11.5.3 Pharmacovigilance Market Size & Forecast, By Service Provider, 2022 – 2035
  11.5.4 Pharmacovigilance Market Size & Forecast, By Type, 2022 – 2035
  11.5.5 Pharmacovigilance Market Size & Forecast, By Process Flow, 2022 – 2035
  11.5.6 Pharmacovigilance Market Size & Forecast, By Therapeutic Area, 2022 – 2035
  11.5.7 Pharmacovigilance Market Size & Forecast, By End Use, 2022 – 2035
  11.5.8 Pharmacovigilance Market Size & Forecast, By Country, 2022 – 2035
   11.5.8.1 Brazil
   11.5.8.2 Argentina
   11.5.8.3 Mexico
   11.5.8.4 Colombia
   11.5.8.5 Rest of Latin America

 11.6 Middle East & Africa
  11.6.1 Key Trends
  11.6.2 Pharmacovigilance Market Size & Forecast, By Product Life Cycle, 2022 – 2035
  11.6.3 Pharmacovigilance Market Size & Forecast, By Service Provider, 2022 – 2035
  11.6.4 Pharmacovigilance Market Size & Forecast, By Type, 2022 – 2035
  11.6.5 Pharmacovigilance Market Size & Forecast, By Process Flow, 2022 – 2035
  11.6.6 Pharmacovigilance Market Size & Forecast, By Therapeutic Area, 2022 – 2035
  11.6.7 Pharmacovigilance Market Size & Forecast, By End Use, 2022 – 2035
  11.6.8 Pharmacovigilance Market Size & Forecast, By Country, 2022 – 2035
   11.6.8.1 UAE
   11.6.8.2 Saudi Arabia
   11.6.8.3 Qatar
   11.6.8.4 Egypt
   11.6.8.5 South Africa
   11.6.8.6 Rest of Middle East & Africa

12. Competitive Landscape
 12.1 Key Players' Positioning
 12.2 Competitive Developments
  12.2.1 Key Strategies Adopted (%), By Key Players, 2025
  12.2.2 Year-Wise Strategies & Development, 2021 – 2025
  12.2.3 Number Of Strategies Adopted By Key Players, 2025
 12.3 Market Share Analysis, 2025
 12.4 Product/Service & Application Benchmarking
  12.4.1 Product/Service Specifications & Features By Key Players
  12.4.2 Product/Service Heatmap By Key Players
  12.4.3 Application Heatmap By Key Players
 12.5 Industry Start-Up & Innovation Landscape
 12.6 Key Company Profiles
  12.6.1 IQVIA Holdings Inc.
   12.6.1.1 Company Overview & Snapshot
   12.6.1.2 Product/Service Portfolio
   12.6.1.3 Key Company Financials
   12.6.1.4 SWOT Analysis
  12.6.2 Accenture plc
  12.6.3 Oracle Corporation
  12.6.4 PAREXEL International Corporation
  12.6.5 Cognizant Technology Solutions
  12.6.6 ArisGlobal LLC
  12.6.7 Syneos Health
  12.6.8 ICON plc
  12.6.9 Pharmaceutical Product Development (PPD)
  12.6.10 Laboratory Corporation of America (Labcorp Drug Development)
  12.6.11 Wipro Limited
  12.6.12 Capgemini SE
  12.6.13 Medpace Holdings, Inc.
  12.6.14 Freyr Solutions
  12.6.15 Veeva Systems Inc.
  12.6.16 Genpact Limited
  12.6.17 BioClinica (Clario)
  12.6.18 PRA Health Sciences
  12.6.19 Pfizer CentreOne
  12.6.20 Ergomed plc
  12.6.21 TAKE Solutions Limited
  12.6.22 Celegence (ITClinical)
  12.6.23 United BioSource Corporation (UBC)
  12.6.24 DrugSafety Services
  12.6.25 SIRO Clinpharm

13. Analyst Recommendations
 13.1 SNS Insider Opportunity Map
 13.2 Industry Low-Hanging Fruit Assessment
 13.3 Market Entry & Growth Strategy
 13.4 Analyst Viewpoint & Suggestions on Market Growth

14. Assumptions

15. Disclaimer

16. Appendix
 16.1 List Of Tables
 16.2 List Of Figures